Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: A complex chromosomal rearrangement of underestimated frequency in disease progression?

Genes Chromosomes and Cancer

Volumn 47, Issue 12, 2008, Pages 1110-1117

  Deluche, Lauréline ^a   Joha, Sami ^a   Corm, Sélim ^b   Daudignon, Agnès ^c   Geffroy, Sandrine ^b   Quief, Sabine ^a   Villenet, Céline ^a   Kerckaert, Jean Pierre ^a   Laï, Jean Luc ^a,b   Preudhomme, Claude ^a,b   Roche Lestienne, Catherine ^a,b  

^a JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Hematology Immunology and Cytogenetics Department   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DASATINIB; IMATINIB; NILOTINIB; PRDM16 PROTEIN; PROTEIN; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CD34 SELECTION; CHROMOSOME 1P; CHROMOSOME 21; CHROMOSOME BREAKAGE; CHROMOSOME DUPLICATION; CHROMOSOME REARRANGEMENT; CHRONIC MYELOID LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DISEASE COURSE; DRUG DOSE INCREASE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DELETION; GENE FREQUENCY; GENE FUSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; MOLECULAR GENETICS; ONCOGENE; PRDM16 GENE; PRIORITY JOURNAL; RUNX1 GENE;

EID: 57149102896     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20611     Document Type: Article

References (21)

1. Calabretta B, Perrotti D. 2004. The biology of CML blast crisis. Blood 103:4010-4022.
2. Du Y, Jenkins NA, Copeland NG. 2005. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 106:3932-3939.
3. Faderl S, Kantarjian HM, Talpaz M. 1999. Chronic myelogenous leukemia: Update on biology and treatment. Oncology (Williston Park) 13:169-180; discussion at 181, 184.
4. Hazourli S, Chagnon P, Sauvageau M, Fetni R, Busque L, Hebert J. 2006. Overexpression of PRDM16 in the presence and absence of the RUNX1/PRDM16 fusion gene in myeloid leukemias. Genes Chromosomes Cancer 45:1072-1076.
5. Jiang GL, Huang S. 2000. The yin-yang of PR-domain family genes in tumorigenesis. Histol Histopathol 15:109-117.
6. Melo JV, Barnes DJ. 2007. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 7:441-453.
7. Mochizuki N, Shimizu S, Nagasawa T, Tanaka H, Taniwaki M, Yokota J, Morishita K. 2000. A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood 96:3209-3214.
8. Modlich U, Schambach A, Brugman MH, Wicke DC, Knoess S, Li Z, Maetzig T, Rudolph C, Schlegelberger B, Baum C. 2008. Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16. Leukemia 22:1519-1528.
9. Morishita K, Parganas E, William CL, Whittaker MH, Drabkin H, Oval J, Taetle R, Valentine MB, Ihle JN. 1992. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci USA 89:3937-3941.
10. Nishikata I, Sasaki H, Iga M, Tateno Y, Imayoshi S, Asou N, Nakamura T, Morishita K. 2003. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation. Blood 102:3323-3332.
11. Preudhomme C, Warot-Loze D, Roumier C, Grardel-Duflos N, Garand R, Lai JL, Dastugue N, Macintyre E, Denis C, Bauters F, Kerckaert JP, Cosson A, Fenaux P. 2000. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. Blood 96:2862-2869.
12. Roche-Lestienne C, Deluche L, Corm S, Tigaud I, Joha S, Philippe N, Geffroy S, Lai JL, Nicolini FE, Preudhomme C. 2008. RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance. Blood 111:3735-3741.
13. Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, Preudhomme C. 2003. New mechanisms of AML1 gene alteration in hematological malignancies. Leukemia 17:9-16.
14. Sakai I, Tamura T, Narumi H, Uchida N, Yakushijin Y, Hato T, Fujita S, Yasukawa M. 2005. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22). Genes Chromosomes Cancer 44:265-270.
15. Shaffer LG, Tommerup LG, editors. 2005. An International System for Human Cytogenetic Nomenclature (ISCN). Basel: S. Karger.
16. Shing DC, Trubia M, Marchesi F, Radaelli E, Belloni E, Tapinassi C, Scanziani E, Mecucci C, Crescenzi B, Lahortiga I, et al. 2007. Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice. J Clin Invest 117:3696-3707.
17. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D, Ratajczak J, Resende IC, Haworth C, Hock R, et al. 1999. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 23:166-175.
18. Steele-Perkins G, Fang W, Yang XH, Van Gele M, Carling T, Gu J, Buyse IM, Fletcher JA, Liu J, Bronson R, et al. 2001. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev 15: 2250-2262.
19. Taketani T, Taki T, Takita J, Tsuchida M, Hanada R, Hongo T, Kaneko T, Manabe A, Ida K, Hayashi Y. 2003. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies. Genes Chromosomes Cancer 38:1-7.
20. Xiao Z, Zhang M, Liu X, Zhang Y, Yang L, Hao Y. 2006. MEL1S, not MEL1, is overexpressed in myelodysplastic syndromes patients with t(1;3)(p36;q21). Leuk Res 30:332-334.
21. Yoshida M, Nosaka K, Yasunaga J, Nishikata I, Morishita K, Matsuoka M. 2004. Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood 103:2753-2760.